News
Naypyidaw: An earthquake of magnitude 4.1 struck Myanmar on Thursday, a statement by the National Center for Seismology (NCS) ...
New findings have disproved a leading explanation for why an experimental HIV vaccine made subjects more susceptible to the virus, reopening the door for further HIV vaccine efforts based on similar ...
The HIV vector delivers an antisense RNA molecule that is the mirror image of an HIV gene called envelope to the T cells. When the modified T cells are given back to the patient, ...
The lentiviral vector, modified from HIV-1, was known to infect non-dividing cells (3). A lentiviral vector system was then developed in an attempt to find a viral vector system that could achieve ...
HIV trial vector specter. Did patients in a failed HIV vaccine trial halted in 2007 become more susceptible to the virus due to the adenoviral vector used to deliver the experimental vaccine?
HIV Vector Licks Leukemia. December 10, 2012. A gene therapy that uses infusions of patients’ own T cells genetically engineered to attack their tumors enjoyed its first successful and sustained ...
The HIV vector delivers an antisense RNA molecule that is the mirror image of an HIV gene called envelope to the T cells. When the modified T cells are given back to the patient, ...
Scientists have developed a prototype HIV vaccine vector using a similar approach to that used for a vaccination for Ebola and Malaria. A team of scientists at Royal Holloway, led by Professor ...
HIV Virus Used As Vector To Get Gene Therapy Into Six Children. Written by Honor Whiteman on July 16, 2013. The HIV Virus can be used to treat two severe genetic diseases, ...
Other, early-phased HIV vaccine trials are using the Ad5 vector. Those will be reevaluated in light of the new findings, Hammer says. "My own feeling is it's curtains for the Ad5 vector," Hammer says.
7mon
GlobalData on MSNGilead adds investigational HIV vaccine to its portfolio from Spanish biotechThe companies first linked up in 2018 to investigate Aelix’s vaccine with Gilead’s antiviral vesatolimod in HIV-infected ...
We have recently described a novel, stable human immunodeficiency virus type 1 (HIV-1) vector packaging system, STAR. High-titre HIV-1 vectors bearing gammaretrovirus envelopes (Env) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results